Horizontal transmission of Marek's disease virus requires US2, the UL13 protein kinase, and gC
about
Herpesvirus telomeric repeats facilitate genomic integration into host telomeres and mobilization of viral DNA during reactivationVirus and host genomic, molecular, and cellular interactions during Marek's disease pathogenesis and oncogenesisHerpesvirus telomerase RNA(vTR)-dependent lymphoma formation does not require interaction of vTR with telomerase reverse transcriptase (TERT).Sequence variability in clinical and laboratory isolates of herpes simplex virus 1 reveals new mutations.Viral control of vTR expression is critical for efficient formation and dissemination of lymphoma induced by Marek's disease virus (MDV).Further analysis of Marek's disease virus horizontal transmission confirms that U(L)44 (gC) and U(L)13 protein kinase activity are essential, while U(S)2 is nonessential.Herpesvirus telomerase RNA (vTR) with a mutated template sequence abrogates herpesvirus-induced lymphomagenesis.A single-amino-acid substitution in herpes simplex virus 1 envelope glycoprotein B at a site required for binding to the paired immunoglobulin-like type 2 receptor alpha (PILRalpha) abrogates PILRalpha-dependent viral entry and reduces pathogenesisDual infection and superinfection inhibition of epithelial skin cells by two alphaherpesviruses co-occur in the natural host.Rho-ROCK and Rac-PAK signaling pathways have opposing effects on the cell-to-cell spread of Marek's Disease VirusIn vitro model for lytic replication, latency, and transformation of an oncogenic alphaherpesvirus.Fluorescently tagged pUL47 of Marek's disease virus reveals differential tissue expression of the tegument protein in vivoHerpes simplex virus 1 VP22 regulates translocation of multiple viral and cellular proteins and promotes neurovirulence.Marek's disease virus expresses multiple UL44 (gC) variants through mRNA splicing that are all required for efficient horizontal transmission.A herpesvirus ubiquitin-specific protease is critical for efficient T cell lymphoma formation.ESCDL-1, a new cell line derived from chicken embryonic stem cells, supports efficient replication of Mardiviruses.Identification of a physiological phosphorylation site of the herpes simplex virus 1-encoded protein kinase Us3 which regulates its optimal catalytic activity in vitro and influences its function in infected cells.Marek's disease virus late protein expression in feather follicle epithelial cells as early as 8 days postinfectionDifferences in the regulatory and functional effects of the Us3 protein kinase activities of herpes simplex virus 1 and 2.Recombinant Marek's Disease Virus as a Vector-Based Vaccine against Avian Leukosis Virus Subgroup J in Chicken.Evolution and diversity in human herpes simplex virus genomes.Differentially expressed genes during spontaneous lytic switch of Marek's disease virus in lymphoblastoid cell lines determined by global gene expression profiling.Multiple Roles of the Cytoplasmic Domain of Herpes Simplex Virus 1 Envelope Glycoprotein D in Infected Cells.Interindividual Spread of Herpesviruses.Herpes simplex virus 1 protein kinase Us3 phosphorylates viral envelope glycoprotein B and regulates its expression on the cell surface.Genomic deletions and mutations resulting in the loss of eight genes reduce the in vivo replication capacity of Meleagrid herpesvirus 1.Removal of Inserted BAC after linearizatiON (RIBON)-a novel strategy to excise the mini-F sequences from viral BAC vectors.Identification and characterization of duck plague virus glycoprotein C gene and gene product.Role of the short telomeric repeat region in Marek's disease virus replication, genomic integration, and lymphomagenesis.Equine herpesvirus 1 entry via endocytosis is facilitated by alphaV integrins and an RSD motif in glycoprotein D.Marek's disease viral interleukin-8 promotes lymphoma formation through targeted recruitment of B cells and CD4+ CD25+ T cellsFluorescent tagging of VP22 in N-terminus reveals that VP22 favors Marek's disease virus (MDV) virulence in chickens and allows morphogenesis study in MD tumor cells.Induction of DNA damages upon Marek's disease virus infection: implication in viral replication and pathogenesis.Discordant varicella-zoster virus glycoprotein C expression and localization between cultured cells and human skin vesicles.Self-excision of the BAC sequences from the recombinant Marek's disease virus genome increases replication and pathogenicity.Attenuation of a very virulent Marek's disease herpesvirus (MDV) by codon pair bias deoptimization.Epstein-Barr virus-encoded RNAs (EBERs) complement the loss of Herpesvirus telomerase RNA (vTR) in virus-induced tumor formation.Dynamic equilibrium of Marek's disease genomes during in vitro serial passage.Cellular Stress Response to Varicella-Zoster Virus Infection of Human Skin Includes Highly Elevated Interleukin-6 Expression
P2860
Q24596192-E8D811AA-32BF-4872-B12D-195092B85F96Q28075941-57AAF9F5-14E4-47C4-95DF-85C205CAF3E6Q33701712-73CD403E-C1E8-49DD-BAD2-A585AFC07325Q33826925-A8E09454-1609-4C97-ADA2-D24E1E48079FQ33896387-2AAC8979-B49E-487C-9530-F5EEB1E2636EQ33963979-8D71C903-5BAF-4A1B-B583-026A7CA50C5BQ34064216-068262CB-1F8C-47E8-AC7E-39C51AD91AE1Q34178357-C673891F-D4D5-4B90-9829-04E9B220C9F9Q34281878-0E5A764C-7CDC-4338-BFE5-394057EA861CQ34406193-335C4E54-1255-4D10-9252-7FEA6D2F1EBCQ35740347-F50E9FD1-6B4E-45A3-BE19-F9C81718804EQ35826098-69EB8B52-02A8-4134-94B7-D6523892529FQ35943800-D18FB9E2-A85C-4989-A75F-0DE3D36467AEQ36171893-9B12C6A6-B896-4D7F-99A0-67824A7AA499Q36289021-25407E4D-D388-4438-9B5F-18310A86035EQ36346040-B986F20E-157C-4B44-9DE0-2A4AA8B99A60Q36748068-88FAE379-786F-4B55-983F-B4C37CBB49F2Q36784582-D072D405-51B5-43CF-939A-88010332B032Q37410706-C2D4E36C-FC44-45DF-9A5B-CBD0F6C153F5Q37450167-193369C1-A32D-4A2D-83B5-EF1903D38193Q37547447-00B77A35-319C-4F97-9237-763F6347FAFAQ38704709-B1B1D2F1-7516-41C8-A4CC-460F21F48914Q38736162-EA1E74F8-F482-47F7-92CE-E4DC11F3C126Q39320366-CBD51B16-24D4-475C-A9D7-77F7FEBFEF86Q39926347-C409FA8A-CD46-4C84-AE0B-FDA1A1EFDD45Q40763156-87A84892-333F-4F9B-9731-D4D03C67E73DQ40819777-2D211D41-61CC-4E8A-A623-0A53F89FCD42Q41253220-FD07EBBE-5B9C-4B49-82DD-C9745DF439D3Q41719257-0E4AAFEA-45C7-4C70-A11B-50E4BC471ECBQ41815389-F173D7E2-5E1C-44B6-9C8F-016859943E21Q41818456-AF8A1334-1D40-4B4A-879A-BB811AD83169Q41886743-9022A4F3-40E8-4543-BC60-D9E50A9B410AQ41924225-64546E3D-6E49-4F4C-9E7D-E521E093B33BQ42573780-04E4801D-462E-48F0-8FF6-3DA7CE546F65Q43052703-EDF81689-6A81-4374-B6DF-006351AD4EC7Q47548276-FAF3725C-DB59-4901-A533-E08012B06040Q47556268-73835DA3-D481-44D1-818A-AA1063B53364Q53149391-672EE66F-E9C0-4285-8EEE-F3D8ED166CFEQ57023788-267D6BDA-BE33-4AD1-A830-119678C7DC1F
P2860
Horizontal transmission of Marek's disease virus requires US2, the UL13 protein kinase, and gC
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Horizontal transmission of Mar ...... he UL13 protein kinase, and gC
@ast
Horizontal transmission of Mar ...... he UL13 protein kinase, and gC
@en
type
label
Horizontal transmission of Mar ...... he UL13 protein kinase, and gC
@ast
Horizontal transmission of Mar ...... he UL13 protein kinase, and gC
@en
prefLabel
Horizontal transmission of Mar ...... he UL13 protein kinase, and gC
@ast
Horizontal transmission of Mar ...... he UL13 protein kinase, and gC
@en
P2860
P50
P356
P1433
P1476
Horizontal transmission of Mar ...... he UL13 protein kinase, and gC
@en
P2093
Neil G Margulis
Stephen J Spatz
P2860
P304
10575-10587
P356
10.1128/JVI.01065-07
P407
P577
2007-07-18T00:00:00Z